Home
About
Services
GxP QMS SolutionsAI Strategy & SolutionsOperations and OptimizationProject ManagementChange Management & Organizational CultureCollaborative Consulting Network
Our Process
Contact Us
Contact Us
Contact Us

Newsletter

Applying AI Where it Matters Most

Thank you for continuing to be part of the Ascendia Clinical community. As we moved through Q2, one theme remained clear: sponsors and clinical teams are being asked to do more with greater precision, stronger oversight, and fewer delays.

‍

This quarter, our conversations focused on practical execution across clinical operations, quality, vendor oversight, and emerging technology. Teams are looking for ways to reduce complexity while maintaining control over the decisions that matter most.

‍

In this edition, we highlight key areas from Q2, including flexible support models, the experience behind Ascendia’s work, ongoing conversations from The Clinical Current, and the evolving role of AI in clinical operations.

As AI becomes more visible across the clinical trial landscape, the opportunity is real—but so is the responsibility. The greatest value will come from pairing new tools with experienced judgment, secure processes, and clear decision-making.

‍

Looking ahead, Ascendia Clinical remains focused on helping sponsors strengthen execution, manage risk, and move forward with confidence.

‍

Ascendia Clinical

In this newsletter
you can expect:

    Applying AI Where it Matters Most

    AI MOVES FROM POSSIBILITY TO PRACTICAL USE

    Across clinical development, AI is quickly moving from a future-facing idea to a practical tool for improving efficiency, visibility, and decision-making.

    ‍

    As interest grows, teams are asking more focused questions: where does AI fit, how should it be governed, what data can it safely access, and how should outputs be reviewed?

    This shift marks a more responsible phase of AI adoption—one centered on oversight, validation, and human judgment.

    ‍

    For sponsors, the opportunity is not to replace experienced clinical leadership, but to strengthen it. With the right controls in place, AI can help teams organize complexity, surface insights faster, and support better decisions. Ascendia Clinical remains focused on helping teams balance innovation with clarity, control, and compliance.

    Partner Spotlight

    Chris is the principal consultant and founder of QACV Consulting, a compliance, quality assurance, and computer systems validation consulting firm supporting regulated industry organizations.

    ‍

    With more than 30 years of experience, he brings deep expertise in compliance, data integrity, auditing, training, and quality improvement.

    ‍

    As a trusted community partner and resource to Ascendia, Chris and the compliance team at QACV consultants provide a valuable perspective on quality, compliance, and technology-driven operational excellence in QA and regulatory compliance.

    THE CLINICAL CURRENT PODCAST

    In this special three-year anniversary episode of Clinical Current, Teresa Hines is joined by Ascendia co-founders Amy Klawitter and Ron Cherubin to discuss Ascendia FLEX—why it was created, how it supports sponsors across Assist, Core, and Plus models, and how flexible expertise helps teams stay agile without sacrificing quality or control.

    Applying AI Where it Matters Most

    AI is quickly becoming part of the clinical trial conversation, but the question for sponsors is no longer whether AI has potential. The more important question is where it can create measurable value without adding confusion, risk, or unnecessary complexity.

    ‍

    In Maximizing the Value of AI in Clinical Trials: Where to Focus First, Ascendia Clinical explores why AI adoption often stalls when teams try to apply it too broadly or without clear operational direction. The article emphasizes the importance of starting with assessment: identifying where time is being lost, where manual review is slowing progress, and where critical signals may be difficult to see.

    From there, the focus shifts to practical implementation. AI is most valuable when it is connected to clear use cases, integrated into existing workflows, and supported by trained teams who know how to validate, interpret, and act on its outputs.

    ‍

    For sponsors and clinical teams, the takeaway is clear: AI works best when it strengthens operational discipline. With the right strategy, oversight, and human expertise in place, it can help improve visibility, consistency, and decision-making across clinical trial operations.

    Progress Through Partnership

    As we look back on Q3, one theme continues to stand out: progress in clinical development rarely comes from adding more activity alone. It comes from having the right people, the right perspective, and the right support at the moment it matters most.

    ‍

    This quarter, Ascendia continued working alongside sponsors and clinical teams as they navigated recruitment challenges, operational demands, quality considerations, and evolving program needs. Whether supporting teams in the field or helping leaders think through the next phase of a project, the focus remained the same: practical expertise, applied where it can make the greatest difference.

    In this issue, we’re highlighting some of that work—from recent community activity and a spotlight on Ron Cherubini, to perspectives on strategic clinical support and the role trusted relationships play throughout the industry.

    ‍

    As clinical programs continue to change, Ascendia remains focused on helping teams move forward with greater clarity, flexibility, and confidence.

    ‍

    Ascendia Clinical

    In this newsletter
    you can expect:

      Progress Through Partnership

      Community News

      ASCENDIA IN THE FIELD

      ‍

      This quarter, members of the Ascendia team traveled to New Orleans to support recruitment efforts directly at the site level.

      ‍

      The work included meeting with site coordinators, connecting with physicians, and helping identify opportunities to strengthen recruitment activity.

      It’s a good example of the way Ascendia approaches clinical support—not from a distance, but by getting close to the challenges teams are actually facing.

      ‍

      That hands-on perspective helps uncover practical opportunities, strengthen communication, and keep recruitment efforts moving forward.

      Collaborator Spotlight

      Ron Cherubini brings more than 25 years of pharmaceutical industry experience spanning clinical process improvement, quality systems, regulatory compliance, and cross-functional strategy.

      ‍

      His experience across pharmaceutical, biotech, and medical device organizations gives him a practical, systems-focused perspective on complex challenges.

      ‍

      At Ascendia, Ron helps teams strengthen processes, manage risk, and develop solutions designed to work in the real world—not just on paper.

      THOUGHT LEADERSHIP

      When clinical teams are stretched, adding another resource can feel like the obvious solution. But additional headcount doesn’t always address the reason progress has slowed.

      ‍

      Sometimes the greater need is experienced clinical expertise that can assess the situation, identify gaps, recommend a path forward, and adapt as the program evolves.

      ‍

      That distinction is at the heart of Ascendia’s approach: supporting teams with the right expertise, at the right level, for the challenge in front of them.

      Progress Through Partnership

      There’s a familiar moment in clinical development when the workload starts outpacing the team. Timelines tighten, priorities shift, and internal resources are stretched across multiple programs.

      ‍

      The natural question is often: Do we need more people?

      ‍

      Sometimes, yes. But adding another person doesn’t necessarily solve the reason progress has slowed.


      Traditional staff augmentation is effective when the need is clear: the sponsor knows what needs to be done, understands the skills required, and needs additional capacity to execute the work.

      Strategic clinical support addresses a different need.


      It brings experienced professionals who can assess the situation, identify gaps, recommend a path forward, anticipate downstream risks, and adapt as study or organizational needs change.

      ‍

      The distinction is important because headcount and progress aren’t always the same thing. Before filling another seat, consider asking:
      ‍

      What expertise do we need to move this forward?


      That question can lead to a very different kind of support—and a more effective path forward. Read the full article at AscendiaClinical.com

      Thank you for reading!
      ASCENDIA CLINICAL
      (484) 951 3791
      www.ascendiaclinical.com
      5873 Winterberry Place
      Allentown, PA 18104

      Ascendia Clinical delivers expert consulting solutions for the Biotechnology and Pharmaceutical industries, with a focus on integrity, collaboration, and results. Partner with us for tailored strategies that drive your success.

      Connect With Us
      ©2026 Ascendia Clinical. All Rights Reserved.
      Website Design by MediaBrewer